HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Development of nobiliside A loaded liposomal formulation using response surface methodology.

Abstract
To reduce the hemolysis and toxicity of nobiliside A (Nob), liposomes were used as a carrier in this study. Response surface methodology (RSM) based on central composite rotatable design (CCRD) was applied for formulation optimization. Phosphatidyl choline (PC) proportion, cholesterol (CH) proportion, and lipids/drug ratio were selected as the independent variables while the encapsulation efficiency (EE) and hemolytic rate (HR) of the liposomes as the dependent variables. The results indicated CH proportion and lipids/drug ratio were the major contributing variables for EE and PC/CH ratio was the major contributing variables for HR. The optimum formulation of Nob liposomes, in which PC proportion of 2% (w/v), CH proportion of 0.9% (w/v), and lipids/drug ratio (w/w) of 40, had higher EE (>95%) and lower HR (<1% at the concentration of 80 microg mL(-1)) with spherical shape and uniform sizes. The intravenous LD50 increased to 9.5 mg kg(-1) compared to 4.1 mg kg(-1) of Nob solution. In conclusion, the liposome was a safety and effective carrier for intravenous Nob.
AuthorsYang Xiong, Dan Guo, Lili Wang, Xiaoli Zheng, Yue Zhang, Jianming Chen
JournalInternational journal of pharmaceutics (Int J Pharm) Vol. 371 Issue 1-2 Pg. 197-203 (Apr 17 2009) ISSN: 1873-3476 [Electronic] Netherlands
PMID19162146 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • 3-O-xylopyranosylholosta-7,9(11),22,24-tetraene-3,17-diol
  • Liposomes
  • Saponins
Topics
  • Animals
  • Chromatography, High Pressure Liquid
  • Drug Compounding (methods)
  • Drug Stability
  • Erythrocytes (drug effects)
  • Female
  • Hemolysis (drug effects)
  • Lethal Dose 50
  • Liposomes
  • Male
  • Mice
  • Mice, Inbred ICR
  • Microscopy, Electron, Transmission
  • Molecular Structure
  • Particle Size
  • Rabbits
  • Saponins (administration & dosage, chemistry, toxicity)
  • Surface Properties
  • Ultrasonics

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: